October 1, 1997Journal of Cardiovascular Electrophysiology
Newer Clinical Applications of Pacing
Key result
Permanent cardiac pacing indications have expanded to include hypertrophic cardiomyopathy, dilated cardiomyopathy, long QT syndrome, and prevention of atrial fibrillation.
Population
Patients with hypertrophic cardiomyopathy, dilated cardiomyopathy, long QT syndrome, or those at risk for…
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports expanded pacing consideration in HCM and LQTS; leaves open randomized confirmation for DCM and AF prevention.
Structured PICO
P
Population
Patients with hypertrophic cardiomyopathy, dilated cardiomyopathy, long QT syndrome, or those at risk for atrial fibrillation
I
Intervention
Permanent cardiac pacing (including dual site atrial pacing for atrial fibrillation prevention)
This review highlights the expanding indications for permanent cardiac pacing beyond traditional AV block and sinus node dysfunction, particularly in hypertrophic cardiomyopathy and long QT syndrome.
Limitations
- Unknowns about selection of patients and long-term benefits in hypertrophic cardiomyopathy
- No data to suggest improved longevity in dilated cardiomyopathy
- Too early to predict long-term success for prevention of atrial fibrillation
Cite This Study
Glikson et al. (1997) conducted a review in Hypertrophic cardiomyopathy, dilated cardiomyopathy, atrial fibrillation, long QT syndrome. Permanent cardiac pacing was evaluated. Permanent cardiac pacing indications have expanded to include hypertrophic cardiomyopathy, dilated cardiomyopathy, long QT syndrome, and prevention of atrial fibrillation.